Notice of Annual General Meeting and Explanatory Memorandum
June 19, 2020
TAKE NOTICE that the Annual General Meeting of Shareholders of the Company will be held at the time, date and place specified below: Time: 11.00 am
Category: Investor updates
Market Herald Interview
June 3, 2020
In May, Imagion signed a collaboration agreement with Siemens Healthineers to explore the utility of our MagSense nanoparticles as a contrast agent in MRI scanning.
Imagion Nanoparticle Manufacturing Update
May 26, 2020
Imagion Biosystems Limited is pleased to report that the first phase of manufacturing of the MagSense® HER2 nanoparticle formulation under Good Manufacturing Practice (GMP) conditions
Imagion Biosystems Establishes Collaboration with Siemens Healthineers
May 20, 2020
Imagion Biosystems Limited announces it has entered into a collaboration agreement with Siemens Healthcare Pty Ltd of Australia (Siemens Healthineers) to further explore the utility
Imagion Biosystems Nanoparticles Used in Viral Therapy Research
May 20, 2020
Imagion Biosystems Limited is pleased to share news of a recent publication, led by researchers at the Weill Cornell Medical College, which reports use of
Imagion Biosystems May 2020 Investor Newsletter
May 14, 2020
Imagion Biosystems Limited is pleased to provide investors with its May 2020 Investor Newsletter. The newsletter details recent key company developments and activities including: Message
Initial Director’s Interest Notice – Dianne Angus
May 11, 2020
Imagion Biosystems Limited has announced “Appendix 3X: Initial Director’s Interest Notice.” Read Appendix 3X.
Imagion Appoints New Non-Executive Director
May 11, 2020
Imagion Biosystems Limited today announced the appointment of Ms Dianne Angus to the Board of Directors. Ms Angus joined the Board as a Non-Executive Director
Imagion Directors Take Up Entitlement in Rights Offers
May 1, 2020
Five Appendices 3Y, “Change of Director’s Interest Notice”, have been released to announce the entitlement right offers taken up by Imagion Directors. Read the Appendices
Appendix 4G
April 30, 2020
Imagion Biosystems has released Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations. Read Appendix 4G